{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T22:52:36Z","timestamp":1767826356842,"version":"3.49.0"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001691","name":"JSPS","doi-asserted-by":"publisher","award":["26860664"],"award-info":[{"award-number":["26860664"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"JSPS","doi-asserted-by":"publisher","award":["15K09337"],"award-info":[{"award-number":["15K09337"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","jni-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Neuroimmunology"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1016\/j.jneuroim.2017.07.006","type":"journal-article","created":{"date-parts":[[2017,7,19]],"date-time":"2017-07-19T12:31:17Z","timestamp":1500467477000},"page":"150-157","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Anti-C1q autoantibodies in patients with neuromyelitis optica spectrum disorders"],"prefix":"10.1016","volume":"310","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8903-8600","authenticated-orcid":false,"given":"Nobuaki","family":"Yoshikura","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akio","family":"Kimura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuichi","family":"Hayashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Inuzuka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jneuroim.2017.07.006_bb0005","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1113\/jphysiol.2002.020818","article-title":"Aquaporin water channels\u2014from atomic structure to clinical medicine","volume":"542","author":"Agre","year":"2002","journal-title":"J. Physiol."},{"key":"10.1016\/j.jneuroim.2017.07.006_bb0010","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1177\/0961203311411597","article-title":"Anti-C1q antibodies have higher correlation with flares of lupus nephritis than other serum markers","volume":"20","author":"Akhter","year":"2011","journal-title":"Lupus"},{"key":"10.1016\/j.jneuroim.2017.07.006_bb0015","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1136\/jnnp.57.8.897","article-title":"Cerebrospinal fluid in the diagnosis of multiple sclerosis: a consensus report","volume":"57","author":"Andersson","year":"1994","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jneuroim.2017.07.006_bb0020","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1002\/ana.21837","article-title":"Neuromyelitis optica: pathogenicity of patient immunoglobulin in vivo","volume":"66","author":"Bradl","year":"2009","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jneuroim.2017.07.006_bb0025","doi-asserted-by":"crossref","first-page":"3701","DOI":"10.1073\/pnas.1017385108","article-title":"Interleukin 6 signaling promotes anti-aquaporin 4 autoantibody production from plasmablasts in neuromyelitis optica","volume":"108","author":"Chihara","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jneuroim.2017.07.006_bb0030","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1177\/1352458506070145","article-title":"Neuromyelitis optica with clinical and histopathological involvement of the brain","volume":"13","author":"Hengstman","year":"2007","journal-title":"Mult. Scler."},{"key":"10.1016\/j.jneuroim.2017.07.006_bb0035","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1212\/01.WNL.0000289761.64862.ce","article-title":"Pathogenic potential of IgG binding to water channel extracellular domain in neuromyelitis optica","volume":"69","author":"Hinson","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2017.07.006_bb0040","first-page":"667","article-title":"High levels of antibodies against Clq are associated with disease activity and nephritis but not with other organ manifestations in SLE patients","volume":"19","author":"Horv\u00e1th","year":"2001","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1016\/j.jneuroim.2017.07.006_bb0045","doi-asserted-by":"crossref","first-page":"71","DOI":"10.3109\/00207450903428970","article-title":"Enhanced IL-6 production in aquaporin-4 antibody positive neuromyelitis optica patients","volume":"120","author":"I\u00e7\u00f6z","year":"2010","journal-title":"Int. J. Neurosci."},{"key":"10.1016\/j.jneuroim.2017.07.006_bb0050","doi-asserted-by":"crossref","first-page":"3072","DOI":"10.1093\/brain\/awn240","article-title":"Antibody to aquaporin-4 in the long-term course of neuromyelitis optica","volume":"131","author":"Jarius","year":"2008","journal-title":"Brain"},{"key":"10.1016\/j.jneuroim.2017.07.006_bb0055","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.jns.2011.03.038","article-title":"Cerebrospinal fluid findings in aquaporin-4 antibody positive neuromyelitis optica: results from 211 lumbar punctures","volume":"306","author":"Jarius","year":"2011","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.jneuroim.2017.07.006_bb0060","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/j.autrev.2008.06.006","article-title":"Anti-C1q autoantibodies","volume":"7","author":"Kallenburg","year":"2008","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.jneuroim.2017.07.006_bb0065","doi-asserted-by":"crossref","first-page":"2176","DOI":"10.1007\/s00415-011-6086-x","article-title":"Cerebrospinal fluid\/serum gradient of IgG is associated with disability at acute attacks of neuromyelitis optica","volume":"258","author":"Kim","year":"2011","journal-title":"J. Neurol."},{"key":"10.1016\/j.jneuroim.2017.07.006_bb0070","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.jneuroim.2012.09.002","article-title":"Increase of complement fragment C5a in cerebrospinal fluid during exacerbation of neuromyelitis optica","volume":"15","author":"Kuroda","year":"2013","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2017.07.006_bb0075","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1016\/S0140-6736(04)17551-X","article-title":"A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis","volume":"364","author":"Lennon","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.jneuroim.2017.07.006_bb0080","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1083\/jcb.200806024","article-title":"Wnt\/\u03b2-catenin signaling controls development of the blood-brain barrier","volume":"183","author":"Liebner","year":"2008","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.jneuroim.2017.07.006_bb0085","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1093\/brain\/awm047","article-title":"Loss of aquaporin 4 in lesions of neuromyelitis optica: distinction from multiple sclerosis","volume":"130","author":"Misu","year":"2007","journal-title":"Brain"},{"key":"10.1016\/j.jneuroim.2017.07.006_bb0090","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.jns.2015.05.011","article-title":"Predictive value of MRI parameters in severity and recovery of first-episode myelitis in aquaporin-4 antibody disease","volume":"355","author":"Murchison","year":"2015","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.jneuroim.2017.07.006_bb0095","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1016\/j.cell.2012.03.047","article-title":"Complement C1q activates canonical Wnt signaling and promotes aging-related phenotypes","volume":"149","author":"Naito","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.jneuroim.2017.07.006_bb0100","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1523\/JNEUROSCI.17-01-00171.1997","article-title":"Specialized membrane domains for water transport in glial cells: high-resolution immunogold cytochemistry of aquaporin-4 in rat brain","volume":"17","author":"Nielsen","year":"1997","journal-title":"J. Neurosci."},{"key":"10.1016\/j.jneuroim.2017.07.006_bb0105","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.jneuroim.2014.07.001","article-title":"Complement activation in patients with neuromyelitis optica","volume":"274","author":"Nytrova","year":"2014","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2017.07.006_bb0110","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/S1474-4422(12)70133-3","article-title":"Aquaporin 4 and neuromyelitis optica","volume":"11","author":"Papadopoulos","year":"2012","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.jneuroim.2017.07.006_bb0115","doi-asserted-by":"crossref","first-page":"13829","DOI":"10.1074\/jbc.M112.344325","article-title":"Complement-dependent cytotoxicity in neuromyelitis optica requires aquaporin-4 protein assembly in orthogonal arrays","volume":"287","author":"Phuan","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jneuroim.2017.07.006_bb0120","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1002\/ana.22366","article-title":"Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria","volume":"69","author":"Polman","year":"2011","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jneuroim.2017.07.006_bb0125","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1093\/brain\/awl371","article-title":"Pattern-specific loss of aquaporin-4 immunoreactivity distinguishes neuromyelitis optica from multiple sclerosis","volume":"130","author":"Roemer","year":"2007","journal-title":"Brain"},{"key":"10.1016\/j.jneuroim.2017.07.006_bb0130","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1093\/brain\/awp309","article-title":"Intra-cerebral injection of neuromyelitis optica immunoglobulin G and human complement produces neuromyelitis optica lesions in mice","author":"Saadoun","year":"2010","journal-title":"Brain"},{"key":"10.1016\/j.jneuroim.2017.07.006_bb0135","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1097\/00041552-200311000-00008","article-title":"Diagnostic and prognostic significance of anti-C1q antibodies in systemic lupus erythematosus","volume":"12","author":"Seelen","year":"2003","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"key":"10.1016\/j.jneuroim.2017.07.006_bb0140","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1007\/s00281-005-0007-y","article-title":"Antibodies against C1q in patients with systemic lupus erythematosus","volume":"27","author":"Trendelenburg","year":"2005","journal-title":"Springer Semin. Immunopathol."},{"key":"10.1016\/j.jneuroim.2017.07.006_bb0145","doi-asserted-by":"crossref","first-page":"3115","DOI":"10.1093\/ndt\/gfl436","article-title":"High prevalence of anti-C1q antibodies in biopsy-proven active lupus nephritis","volume":"21","author":"Trendelenburg","year":"2006","journal-title":"Nephrol. Dial. Tranplantat."},{"key":"10.1016\/j.jneuroim.2017.07.006_bb0150","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1046\/j.1365-2249.2003.02108.x","article-title":"Glomerular deposition of C1q and anti-C1q antibodies in mice following injection of antimouse C1q antibodies","volume":"132","author":"Trouw","year":"2003","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.jneuroim.2017.07.006_bb0155","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1172\/JCI200421075","article-title":"Anti-C1q autoantibodies deposit in glomeruli but are only pathogenic in combination with glomerular C1q-containing immune complexes","volume":"114","author":"Trouw","year":"2004","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jneuroim.2017.07.006_bb0160","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1111\/j.1749-6632.2009.04750.x","article-title":"Relevance of anti-C1q autoantibodies to lupus nephritis","volume":"1173","author":"Tsirogianni","year":"2009","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.jneuroim.2017.07.006_bb0165","first-page":"1073","article-title":"Increased cerebrospinal fluid metalloproteinase-2 and interleukin-6 are associated with albumin quotient in neuromyelitis optica: their possible role on blood-brain barrier disruption","author":"Uchida","year":"2017","journal-title":"Mult. Scler."},{"key":"10.1016\/j.jneuroim.2017.07.006_bb0170","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1001\/archneur.65.7.913","article-title":"Aquaporin-4 antibodies in neuromyelitis optica and longitudinally extensive transverse myelitis","volume":"65","author":"Waters","year":"2008","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.jneuroim.2017.07.006_bb0175","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1212\/WNL.53.5.1107","article-title":"The clinical course of neuromyelitis optica (Devic's syndrome)","volume":"53","author":"Wingerchuk","year":"1999","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2017.07.006_bb0180","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/S1474-4422(07)70216-8","article-title":"The spectrum of neuromyelitis optica","volume":"6","author":"Wingerchuk","year":"2007","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.jneuroim.2017.07.006_bb0185","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1212\/WNL.0000000000001729","article-title":"International consensus diagnostic criteria for neuromyelitis optica spectrum disorders","volume":"14","author":"Wingerchuk","year":"2015","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2017.07.006_bb0190","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1177\/0961203312451202","article-title":"Diagnostic value of serum anti-C1q antibodies in patients with lupus nephritis: a meta-analysis","author":"Yin","year":"2012","journal-title":"Lupus"}],"updated-by":[{"DOI":"10.1016\/j.jneuroim.2017.09.009","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2017,11,15]],"date-time":"2017-11-15T00:00:00Z","timestamp":1510704000000}}],"container-title":["Journal of Neuroimmunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572817301443?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572817301443?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,30]],"date-time":"2019-09-30T20:07:25Z","timestamp":1569874045000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165572817301443"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9]]},"references-count":38,"alternative-id":["S0165572817301443"],"URL":"https:\/\/doi.org\/10.1016\/j.jneuroim.2017.07.006","relation":{"erratum":[{"id-type":"doi","id":"10.1016\/j.jneuroim.2017.09.009","asserted-by":"object"}]},"ISSN":["0165-5728"],"issn-type":[{"value":"0165-5728","type":"print"}],"subject":[],"published":{"date-parts":[[2017,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Anti-C1q autoantibodies in patients with neuromyelitis optica spectrum disorders","name":"articletitle","label":"Article Title"},{"value":"Journal of Neuroimmunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jneuroim.2017.07.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}